Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial

Published:2012-04 Issue:2 Volume:25 Page:169-177
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Dahl Ronald,Titlestad Ingrid,Lindqvist Ari,Wielders Pascal,Wray Heather,Wang Millie,Samuelsson Viktoria,Mo John,Holt Alison

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference39 articles.

1. Biomarkers in COPD: time for a deep breath;Stockley;Thorax,2007

2. COPD: current therapeutic interventions and future approaches;Barnes;Eur Respir J,2005

3. Chronic obstructive pulmonary disease, inflammation and co-morbidity–a common inflammatory phenotype?;Sevenoaks;Respir Res,2006

4. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD;Karadag;Lung,2008

5. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis;Gan;Thorax,2004

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MS;Journal of Chromatography B;2024-09

2. MMPs as potential molecular targets in epithelial-to-mesenchymal transition driven COPD progression;Life Sciences;2024-09

3. Challenge-led, values-based interdisciplinary infrastructure for optical probes, devices, and drugs;Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2024;2024-03-13

4. The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics;Oxidative Medicine and Cellular Longevity;2023-12-21

5. Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target;Respiratory Research;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3